Source:http://linkedlifedata.com/resource/pubmed/id/15948970
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-6-13
|
pubmed:abstractText |
The current understanding of the function of natural killer (NK) T cells in innate immunity and their potential to control acquired specific immunity, as well as the remarkable efficacy of antitumour necrosis factor-alpha biological treatments in psoriasis, forces us to refine the current T-cell hypothesis of psoriasis pathogenesis, and to give credit to the role of innate immunity. Psoriasis might be envisioned to be a genetically determined triggered state of otherwise dormant innate immunity. This aggravated state of innate immunity is represented by the activity of NK T cells, dendritic cells, neutrophils and keratinocytes, leading to the recruitment and activation of preferentially type 1 T cells, possibly in an antigen-independent way. Keratinocytes in psoriasis then are sensitive to the effects of T-cell activation and cytokine production, interferon (IFN)-gamma, by responding with psoriasiform hyperplasia. The chronic inflammation of psoriatic lesions suggests that this might be due to a deficiency in downregulation processes (e.g. a defect in the regulatory T-cell repertoire) and/or the persistence of an unknown trigger resulting in an exaggerated innate immune response.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-0963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
152
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1098-107
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15948970-Antigens,
pubmed-meshheading:15948970-Dendritic Cells,
pubmed-meshheading:15948970-Genetic Predisposition to Disease,
pubmed-meshheading:15948970-Humans,
pubmed-meshheading:15948970-Immunity, Innate,
pubmed-meshheading:15948970-Immunologic Memory,
pubmed-meshheading:15948970-Keratinocytes,
pubmed-meshheading:15948970-Killer Cells, Natural,
pubmed-meshheading:15948970-Lymphocyte Activation,
pubmed-meshheading:15948970-Models, Immunological,
pubmed-meshheading:15948970-Polymorphism, Genetic,
pubmed-meshheading:15948970-Psoriasis,
pubmed-meshheading:15948970-Tumor Necrosis Factor-alpha
|
pubmed:year |
2005
|
pubmed:articleTitle |
Psoriasis: dysregulation of innate immunity.
|
pubmed:affiliation |
Department of Dermatology, Academic Medical Center, University of Amsterdam, P.O.Box 22700, 1100 DE Amsterdam, the Netherlands. j.d.bos@amc.uva.nl
|
pubmed:publicationType |
Journal Article,
Review
|